These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25368022)

  • 1. ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells.
    Sainz B; Martín B; Tatari M; Heeschen C; Guerra S
    Cancer Res; 2014 Dec; 74(24):7309-20. PubMed ID: 25368022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAG3 deletion suppresses stem cell-like features of pancreatic ductal adenocarcinoma via translational suppression of ISG15.
    Li XY; Yan J; Sun J; Li C; Jiang JY; Wang JM; Meng XN; Liang JJ; Wang HQ
    Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):819-827. PubMed ID: 30771383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment.
    Sainz B; Alcala S; Garcia E; Sanchez-Ripoll Y; Azevedo MM; Cioffi M; Tatari M; Miranda-Lorenzo I; Hidalgo M; Gomez-Lopez G; Cañamero M; Erkan M; Kleeff J; García-Silva S; Sancho P; Hermann PC; Heeschen C
    Gut; 2015 Dec; 64(12):1921-35. PubMed ID: 25841238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of interferon-α on the expression of the cancer stem cell markers in pancreatic carcinoma cells.
    Zhu Y; Karakhanova S; Huang X; Deng SP; Werner J; Bazhin AV
    Exp Cell Res; 2014 Jun; 324(2):146-56. PubMed ID: 24726912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
    Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
    Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinoma.
    Vizio B; Mauri FA; Prati A; Trivedi P; Giacobino A; Novarino A; Satolli MA; Ciuffreda L; Camandona M; Gasparri G; Bellone G
    Oncol Rep; 2012 Jan; 27(1):69-76. PubMed ID: 21922151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer stem cells: A state or an entity?
    Hermann PC; Sainz B
    Semin Cancer Biol; 2018 Dec; 53():223-231. PubMed ID: 30130664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of lncRNAs in the development and progression of pancreatic cancer.
    Duguang L; Jin H; Xiaowei Q; Peng X; Xiaodong W; Zhennan L; Jianjun Q; Jie Y
    Cancer Biol Ther; 2017 Dec; 18(12):927-936. PubMed ID: 29053398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CTCF/LncRNA-PACERR complex recruits E1A binding protein p300 to induce pro-tumour macrophages in pancreatic ductal adenocarcinoma via directly regulating PTGS2 expression.
    Liu Y; Wang X; Zhu Y; Cao Y; Wang L; Li F; Zhang Y; Li Y; Zhang Z; Luo J; Deng X; Peng C; Wei G; Chen H; Shen B
    Clin Transl Med; 2022 Feb; 12(2):e654. PubMed ID: 35184402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity.
    Alcalá S; Sancho P; Martinelli P; Navarro D; Pedrero C; Martín-Hijano L; Valle S; Earl J; Rodríguez-Serrano M; Ruiz-Cañas L; Rojas K; Carrato A; García-Bermejo L; Fernández-Moreno MÁ; Hermann PC; Sainz B
    Nat Commun; 2020 May; 11(1):2682. PubMed ID: 32472071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biology and clinical applications of pancreatic cancer stem cells.
    Abel EV; Simeone DM
    Gastroenterology; 2013 Jun; 144(6):1241-8. PubMed ID: 23622133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ISG15 pathway knockdown reverses pancreatic cancer cell transformation and decreases murine pancreatic tumor growth via downregulation of PDL-1 expression.
    Burks J; Fleury A; Livingston S; Smith JP
    Cancer Immunol Immunother; 2019 Dec; 68(12):2029-2039. PubMed ID: 31709456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNMT1 Inhibition Reprograms Pancreatic Cancer Stem Cells via Upregulation of the miR-17-92 Cluster.
    Zagorac S; Alcala S; Fernandez Bayon G; Bou Kheir T; Schoenhals M; González-Neira A; Fernandez Fraga M; Aicher A; Heeschen C; Sainz B
    Cancer Res; 2016 Aug; 76(15):4546-58. PubMed ID: 27261509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumor microenvironment on gene expression in pancreatic cancer tumor models.
    Mees ST; Mardin WA; Schleicher C; Colombo-Benkmann M; Senninger N; Haier J
    J Surg Res; 2011 Nov; 171(1):136-42. PubMed ID: 20605603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular matrix composition modulates PDAC parenchymal and stem cell plasticity and behavior through the secretome.
    Biondani G; Zeeberg K; Greco MR; Cannone S; Dando I; Dalla Pozza E; Mastrodonato M; Forciniti S; Casavola V; Palmieri M; Reshkin SJ; Cardone RA
    FEBS J; 2018 Jun; 285(11):2104-2124. PubMed ID: 29660229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
    Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
    Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metastasis of pancreatic tumors].
    Häberle L; Braren R; Schlitter AM; Esposito I
    Pathologe; 2015 Nov; 36 Suppl 2():176-80. PubMed ID: 26391249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis.
    Egberts JH; Cloosters V; Noack A; Schniewind B; Thon L; Klose S; Kettler B; von Forstner C; Kneitz C; Tepel J; Adam D; Wajant H; Kalthoff H; Trauzold A
    Cancer Res; 2008 Mar; 68(5):1443-50. PubMed ID: 18316608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer.
    Giovannetti E; van der Borden CL; Frampton AE; Ali A; Firuzi O; Peters GJ
    Semin Cancer Biol; 2017 Jun; 44():43-59. PubMed ID: 28438662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.